UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop

BMC health services research, 2021-05, Vol.21 (1), p.412-412, Article 412

2021

Link zum Volltext

Verfügbarkeit prüfen

Indication-specific pricing of pharmaceuticals in the US healthcare system

Journal of comparative effectiveness research, 2017-07, Vol.6 (5), p.397-404

2017

Link zum Volltext

Verfügbarkeit prüfen

Public participation in decision-making on the coverage of new antivirals for hepatitis C

Journal of health organization and management, 2016-08, Vol.30 (5), p.769-785

2016

Link zum Volltext

Verfügbarkeit prüfen

How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice

Health research policy and systems, 2015-01, Vol.13 (1), p.1-1, Article 1

2015

Link zum Volltext

Verfügbarkeit prüfen

USING HEALTH TECHNOLOGY ASSESSMENT TO SUPPORT OPTIMAL USE OF TECHNOLOGIES IN CURRENT PRACTICE: THE CHALLENGE OF “DISINVESTMENT”

International journal of technology assessment in health care, 2012-07, Vol.28 (3), p.203-210

2012

Link zum Volltext

Verfügbarkeit prüfen

Gene therapy: evidence, value and affordability in the US health care system

Journal of comparative effectiveness research, 2018-01, Vol.7 (1), p.15-28

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-world evidence for coverage decisions: opportunities and challenges

Journal of comparative effectiveness research, 2018-12, Vol.7 (12), p.1133-1143

2018

Link zum Volltext

Verfügbarkeit prüfen

ASSESSING VALUE, BUDGET IMPACT, AND AFFORDABILITY IN ASIA

International journal of technology assessment in health care, 2017-01, Vol.33 (2), p.315-322

2017

Link zum Volltext

Verfügbarkeit prüfen

ADAPTIVE APPROACHES TO LICENSING, HEALTH TECHNOLOGY ASSESSMENT, AND INTRODUCTION OF DRUGS AND DEVICES

International journal of technology assessment in health care, 2014-07, Vol.30 (3), p.241-249

2014

Link zum Volltext

Verfügbarkeit prüfen

TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES

International journal of technology assessment in health care, 2016-01, Vol.32 (3), p.160-166

2016

Link zum Volltext

Verfügbarkeit prüfen

The impact of Payback research: developing and using evidence in policy

Research evaluation, 2011-09, Vol.20 (3), p.257-258

Henshall, Chris

2011

Link zum Volltext

Verfügbarkeit prüfen

OP03 Optimizing The Use Of RWE In HTA: Lessons From The ICER Summit

International journal of technology assessment in health care, 2018, Vol.34 (S1), p.1-2

2018

Link zum Volltext

Verfügbarkeit prüfen

TOWARD A SHIFTING HEALTH TECHNOLOGY ASSESSMENT PARADIGM: REACTIONS TO POLICY FORUM DISCUSSIONS

International journal of technology assessment in health care, 2015-01, Vol.31 (4), p.228-229

2015

Link zum Volltext

Verfügbarkeit prüfen

TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALS

International journal of technology assessment in health care, 2016-01, Vol.32 (3), p.167-174

2016

Link zum Volltext

Verfügbarkeit prüfen

VP87 Extrapolation From Progression Free Survival To Overall Survival In Oncology

International journal of technology assessment in health care, 2017, Vol.33 (S1), p.188-189

2017

Link zum Volltext

Verfügbarkeit prüfen

Cornerstones of ‘fair’ drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals

Journal of comparative effectiveness research, 2021-05, Vol.10 (7), p.537-547

2021

Link zum Volltext

Verfügbarkeit prüfen

CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?-ERRATUM

International journal of technology assessment in health care, 2016-01, Vol.32 (6), p.407-407

2016

Link zum Volltext

Verfügbarkeit prüfen

Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit

Journal of comparative effectiveness research, 2019-10, Vol.8 (13), p.1045-1054

2019

Link zum Volltext

Verfügbarkeit prüfen

A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions

Journal of comparative effectiveness research, 2018-12, Vol.7 (12), p.1145-1152

2018

Link zum Volltext

Verfügbarkeit prüfen

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.427-433

2016

Link zum Volltext

Verfügbarkeit prüfen

Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?

Therapeutic innovation & regulatory science, 2014-05, Vol.48 (3), p.341-346

2014

Link zum Volltext

Verfügbarkeit prüfen

Procurement change in Canada: An opportunity for improving system performance

Healthcare management forum, 2012, Vol.25 (2), p.66-69

2012

Link zum Volltext

Verfügbarkeit prüfen

Towards a coordinated approach for managing accelerated patient access to potentially beneficial medicines: reporting the perspectives of a multi-stakeholder, international workshop

Health affairs scholar, 2024-06, Vol.2 (6), p.qxae069-qxae069

2024

Link zum Volltext

Verfügbarkeit prüfen

HEALTH TECHNOLOGY ASSESSMENT IN THE UNITED KINGDOM

International journal of technology assessment in health care, 2000-04, Vol.16 (2), p.591-625

2000

Link zum Volltext

Verfügbarkeit prüfen

SUMMARY REPORT OF THE ECHTA/ECAHI PROJECT

International journal of technology assessment in health care, 2002-04, Vol.18 (2), p.218-237

2002

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library

Zeitschrift / SerieEuropean Journal Of Epidemiology

ThemaHealth

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)

Publikationsform

Artikel
(44)
Tagungsberichte
(2)

Sprache

Englisch
(46)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(26)
Health Care Sciences & Services
(20)
Humans
(15)
Medical Informatics
(11)
Decision Making
(10)
Health Technology Assessment
(10)
Public, Environmental & Occupational Health
(10)
Patients
(8)
Reimbursement
(7)
Policy Making
(6)
Technology
(6)
Animals
(5)
Clinical Trials
(5)
Drugs
(5)
Regulatory Approval
(5)
Case Studies
(4)
Ethics
(4)
Health Care Policy
(4)
Health Policy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Challenges in valuing and paying for combination regimens in oncology: reporting the perspectives of a multi-stakeholder, international workshop

Indication-specific pricing of pharmaceuticals in the US healthcare system

Public participation in decision-making on the coverage of new antivirals for hepatitis C

How long does biomedical research take? Studying the time taken between biomedical and health research and its translation into products, policy, and practice

USING HEALTH TECHNOLOGY ASSESSMENT TO SUPPORT OPTIMAL USE OF TECHNOLOGIES IN CURRENT PRACTICE: THE CHALLENGE OF “DISINVESTMENT”

Gene therapy: evidence, value and affordability in the US health care system

Real-world evidence for coverage decisions: opportunities and challenges

ASSESSING VALUE, BUDGET IMPACT, AND AFFORDABILITY IN ASIA

ADAPTIVE APPROACHES TO LICENSING, HEALTH TECHNOLOGY ASSESSMENT, AND INTRODUCTION OF DRUGS AND DEVICES

TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES

The impact of Payback research: developing and using evidence in policy

OP03 Optimizing The Use Of RWE In HTA: Lessons From The ICER Summit

TOWARD A SHIFTING HEALTH TECHNOLOGY ASSESSMENT PARADIGM: REACTIONS TO POLICY FORUM DISCUSSIONS

TREATMENT SWITCHING IN CANCER TRIALS: ISSUES AND PROPOSALS

VP87 Extrapolation From Progression Free Survival To Overall Survival In Oncology

Cornerstones of ‘fair’ drug coverage: appropriate cost sharing and utilization management policies for pharmaceuticals

CHANGING HEALTH TECHNOLOGY ASSESSMENT PARADIGMS?-ERRATUM

Policy perspectives on alternative models for pharmaceutical rebates: a report from the Institute for Clinical and Economic Review Policy Summit

A framework to guide the optimal development and use of real-world evidence for drug coverage and formulary decisions

Targeting improved patient outcomes using innovative product listing agreements: a survey of Canadian and international key opinion leaders

Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?

Procurement change in Canada: An opportunity for improving system performance

Towards a coordinated approach for managing accelerated patient access to potentially beneficial medicines: reporting the perspectives of a multi-stakeholder, international workshop

HEALTH TECHNOLOGY ASSESSMENT IN THE UNITED KINGDOM

SUMMARY REPORT OF THE ECHTA/ECAHI PROJECT

Aktive Filter

Suchergebnisse filtern